United Therapeutics Inc. (UTHR) Enterprise Value to EBITDA Ratio

Public company logo of unither.com (UTHR)

United Therapeutics (UTHR) maintains high margins driven by unique logistics for the delivery of orphan drugs. The EV/EBITDA level for the company on the GURU.Markets chart illustrates market value relative to earnings, where the 15.74 mark records this metric. Revenue is based on insurance reimbursements for expensive treatments of cardiovascular pathologies. The strategy combines the monetization of the current portfolio with the development of artificial organs.

United Therapeutics Corp - UTHR Company Value to EBITDA (period 11/23/2025 - 11/14/2026)

Comprehensive metric breakdowns and analytics for United Therapeutics Corp (UTHR)

- current price and projected stock value:
Stock Price unither.com|UTHR - Analyst Median Target
- market capitalization details:
Market Valuation United Therapeutics|UTHR - Full Business Value
- business book valuation details:
Book Value per Share United Therapeutics|UTHR - Total Stockholders' Equity|Market Capitalization to Book Value Ratio unither.com|UTHR - Total Business Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio United Therapeutics|UTHR - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity United Therapeutics Corporation|UTHR - Company Aggregate Indebtedness|Debts to Book Capitalization United Therapeutics Corp|UTHR - Company Long-Term Loans and Borrowings|Company Short-Term Debts United Therapeutics|Quick Liquidity unither.com
- financial results and valuation multiples details:
UTHR - Final Profit|Expected Profit United Therapeutics|UTHR - Price to Earnings Ratio|Forward P/E Multiple unither.com|UTHR - PEG Multiple|Enterprise Value to EBITDA Ratio United Therapeutics|UTHR - Operating profit EBITDA|Earnings per share for the last twelve months United Therapeutics|UTHR - Earnings per share for the last 12 months|Quarterly EPS earnings growth unither.com|UTHR - Expected net earnings per share growth this year|Expected earnings per share growth for next year United Therapeutics
- revenue and sales details:
UTHR - Company Total Sales|Projected Sales Volume United Therapeutics Corp|UTHR - Price to Sales|Forward P/S Multiple United Therapeutics Corp.
Fundamental valuation:United Therapeutics UTHR
Manufactured products of United Therapeutics Corporation

This indicator compares the total enterprise value of the business with its operating profit before depreciation, taxes, and interest. By analyzing the EV/EBITDA multiple of United Therapeutics (UTHR) over time, an investor assesses the real value of assets relative to the ability to generate cash flow. The metric is highly sensitive to changes in debt load and borrowing costs. For United Therapeutics (UTHR), this is critical amid growing generic pressure and uncertainty regarding the implementation timelines of innovative developments.

Key competitors

EV/EBITDA Multiple VRTX (vrtx.com)|Total Company Value to Operating Income Before Depreciation Ratio Alnylam (ALNY)|INSM: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio BMRN|BBIO: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation BGM|COGT (Cogent Biosciences, Inc.) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation XERS (Xeris Biopharma Holdings)|Enterprise Value to EBITDA Ratio KROS (Keros Therapeutics, Inc.)|ARCT (Arcturus Therapeutics Inc) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Eton Pharmaceuticals, Inc. ETON|KMDA (Kamada Corp) - Company Value to Operating Income Before Depreciation Ratio|Fulcrum Therapeutics - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation ABEO (abeonatherapeutics.com)|MREO: EV/EBITDA Multiple|Protalix BioTherapeutics Inc. - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization pliantrx.com|APLT: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization aileronrx.com (RNTX)|Enterprise Value to EBITDA Ratio Gelteq GELS|EV/EBITDA Multiple AYTU (Aytu BioPharma Inc)|EV/EBITDA Multiple Chemomab CMMB|SRXH - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PLRZ|AEZS: EV/EBITDA Multiple|Company Value to EBITDA Cyclo Therapeutics (CYTH)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Inozyme Pharma Inc.|Enterprise Value to Operating Income Before Depreciation RPHM (Reneo Pharmaceuticals, Inc.)|EV/EBITDA Multiple CSCI